ONCO:NASDAQ, Onconetix, Inc.

Why ONCO stock fell on November 9

Onconetix, Inc. fell 48.5% on Monday, November 9, 2026, on 738,358 shares. The headline around the move:

Nov 9: Realbotix Provides Update on Nasdaq Listing Timeline

ONCO stock overview

Onconetix, Inc. (ONCO:NASDAQ) closed at $3.58 on November 9, 2026, down 48.49% on the day. The stock trades 99.8% below its 52-week high of $1,610.00 and 7.2% above its 52-week low of $3.34. Over the past year, it lost 73.8%. Onconetix, Inc. is part of the Health Care sector.

Key figures

Price: $3.58
Day change: -48.49%
Volume: 738,358
Average volume: 405,208
Market cap: 2M+
52-week range: $3.34 – $1,610.00
50-day average: $6.51
200-day average: $114.59

Price action over the past year

In 251 trading sessions since November 7, 2025, ONCO closed higher on 94 days (37%). Its best day was November 24, 2025 (+963.35%) and its worst was May 19, 2026 (-61.44%). The stock moved 10% or more in a single session 58 times. It opened at least 5% above the previous day's high 7 times.

Recent signals

Nov 9, 2026: News catalyst: Investor Update (News Catalysts scanner)

ONCO news

Nov 9, 2026: Realbotix Provides Update on Nasdaq Listing Timeline
Oct 28, 2026: BC-Most Active Stocks
Oct 27, 2026: Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement
Oct 26, 2026: Onconetix Announces Reverse Stock Split
Oct 23, 2026: Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
Oct 23, 2026: Realbotix Announces Additional Draw under Bridge Loan from Onconetix
Sep 24, 2026: SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
Sep 14, 2026: CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition

About Onconetix, Inc.

Blue Water Vaccines Inc is a biotechnology company focused on the research and development of transformational vaccines to prevent infectious diseases. Its versatile vaccine platform has molecular properties that enable delivery of various antigens, which can be utilized to develop singular or multi-targeted vaccines.

Similar stocks

Find more stocks like ONCO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.